MDxHealth SA Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing covers the month of February 2026 for MDxHealth SA, a foreign private issuer headquartered in Herstal, Belgium. The report primarily serves to disclose a significant corporate governance change and the issuance of a press release.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event disclosure and does not contain financial statements or performance metrics.
Material Changes
The primary material change disclosed is the appointment of Ron Kalfus as interim Chief Financial Officer, effective February 26, 2026. No financial changes versus prior periods are reported in this document.
Guidance, Outlook, and Risks
The filing references an attached press release (Exhibit 99.1) but does not include its text. Consequently, no specific guidance, outlook, management commentary, risks, or contingencies are detailed within the body of this Form 6-K. The filing notes that the attached press release is furnished and not deemed "filed" for liability purposes under Section 18 of the Exchange Act.
Key Facts for Investor Verification
- Verify the full text of the press release attached as Exhibit 99.1 for details on the interim CFO appointment and any accompanying strategic updates.
- Confirm the background and qualifications of Ron Kalfus in his new role as interim CFO.
- Review subsequent filings for the next available financial data, as this report contains no financial metrics.